BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19555897)

  • 1. Affordable medicines facility for malaria.
    Bate R; Hess K
    Lancet Infect Dis; 2009 Jul; 9(7):396-7. PubMed ID: 19555897
    [No Abstract]   [Full Text] [Related]  

  • 2. An affordable antimalarial.
    Tenenbaum DJ
    Environ Health Perspect; 2004 Jan; 112(1):A25. PubMed ID: 14714543
    [No Abstract]   [Full Text] [Related]  

  • 3. The Global Fund and effective malaria treatment.
    Lidén J; Nantulya VM
    Lancet; 2004 Apr; 363(9418):1396. PubMed ID: 15110502
    [No Abstract]   [Full Text] [Related]  

  • 4. The Affordable Medicines Facility-malaria--a success in peril.
    Talisuna AO; Adibaku S; Amojah CN; Amofah GK; Aubyn V; Dodoo A; Juma E; Jackou DH; Mkude S; Okui AP; Ramarosandratana B; Shija SJ
    Malar J; 2012 Nov; 11():370. PubMed ID: 23137141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Affordable Medicines Facility--malaria.
    Tozan Y; Jahn A; Müller O
    Lancet; 2013 Mar; 381(9872):1095. PubMed ID: 23540849
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of the Affordable Medicines Facility--malaria - Authors' reply.
    Tougher S; Ye Y; Goodman C; Arnold F; Hanson K
    Lancet; 2013 Mar; 381(9872):1095-6. PubMed ID: 23540850
    [No Abstract]   [Full Text] [Related]  

  • 7. The Affordable Medicines Facility--malaria: killing it slowly.
    Arrow KJ; Danzon PM; Gelband H; Jamison D; Laxminarayan R; Mills A; Mwabu G; Panosian C; Peto R; White NJ
    Lancet; 2012 Dec; 380(9857):1889-90. PubMed ID: 23122218
    [No Abstract]   [Full Text] [Related]  

  • 8. The quest for universal access to effective malaria treatment: how can the AMFm contribute?
    Matowe L; Adeyi O
    Malar J; 2010 Oct; 9():274. PubMed ID: 20932286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Public health. From financing to fevers: lessons of an antimalarial subsidy program.
    Laxminarayan R; Arrow K; Jamison D; Bloom BR
    Science; 2012 Nov; 338(6107):615-6. PubMed ID: 23118173
    [No Abstract]   [Full Text] [Related]  

  • 10. Trends in availability and prices of subsidized ACT over the first year of the AMFm: evidence from remote regions of Tanzania.
    Yadav P; Cohen JL; Alphs S; Arkedis J; Larson PS; Massaga J; Sabot O
    Malar J; 2012 Aug; 11():299. PubMed ID: 22929587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Public health. Optimizing investments in malaria treatment and diagnosis.
    Cohen JM; Woolsey AM; Sabot OJ; Gething PW; Tatem AJ; Moonen B
    Science; 2012 Nov; 338(6107):612-4. PubMed ID: 23118172
    [No Abstract]   [Full Text] [Related]  

  • 12. Malaria overdiagnosis and burden of malaria misdiagnosis in the suburbs of central Sudan: special emphasis on artemisinin-based combination therapy era.
    A-Elgayoum SM; El-Feki Ael-K; Mahgoub BA; El-Rayah el-A; Giha HA
    Diagn Microbiol Infect Dis; 2009 May; 64(1):20-6. PubMed ID: 19362256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the Affordable Medicines Facility--malaria (AMFm) on the availability, price, and market share of quality-assured artemisinin-based combination therapies in seven countries: a before-and-after analysis of outlet survey data.
    Tougher S; ; Ye Y; Amuasi JH; Kourgueni IA; Thomson R; Goodman C; Mann AG; Ren R; Willey BA; Adegoke CA; Amin A; Ansong D; Bruxvoort K; Diallo DA; Diap G; Festo C; Johanes B; Juma E; Kalolella A; Malam O; Mberu B; Ndiaye S; Nguah SB; Seydou M; Taylor M; Rueda ST; Wamukoya M; Arnold F; Hanson K
    Lancet; 2012 Dec; 380(9857):1916-26. PubMed ID: 23122217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innovating for impact: the Affordable Medicines Facility-malaria (AMFm).
    Adeyi O; Atun R
    Nat Med; 2009 Sep; 15(9):991. PubMed ID: 19734866
    [No Abstract]   [Full Text] [Related]  

  • 15. Amodiaquine and combination chemotherapy for malaria.
    Meshnick SR; Alker AP
    Am J Trop Med Hyg; 2005 Nov; 73(5):821-3. PubMed ID: 16282286
    [No Abstract]   [Full Text] [Related]  

  • 16. Resistance to the Affordable Medicines Facility for malaria?
    Lancet; 2009 Apr; 373(9673):1400. PubMed ID: 19394517
    [No Abstract]   [Full Text] [Related]  

  • 17. Maximising the public health benefit of antimalarials.
    Price RN; Douglas NM
    Lancet Infect Dis; 2010 Oct; 10(10):654-5. PubMed ID: 20832368
    [No Abstract]   [Full Text] [Related]  

  • 18. Artemisinin-based combination therapies (ACTs): best hope for malaria treatment but inaccessible to the needy!
    Mutabingwa TK
    Acta Trop; 2005 Sep; 95(3):305-15. PubMed ID: 16098946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Making antimalarial agents available in Africa.
    Arrow KJ; Gelband H; Jamison DT
    N Engl J Med; 2005 Jul; 353(4):333-5. PubMed ID: 16000348
    [No Abstract]   [Full Text] [Related]  

  • 20. Artesunate for severe malaria.
    Lancet; 2011 Apr; 377(9776):1466. PubMed ID: 21531257
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.